1. Home
  2. TKNO vs CMPS Comparison

TKNO vs CMPS Comparison

Compare TKNO & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • CMPS
  • Stock Information
  • Founded
  • TKNO 1996
  • CMPS 2020
  • Country
  • TKNO United States
  • CMPS United Kingdom
  • Employees
  • TKNO N/A
  • CMPS N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • CMPS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TKNO Health Care
  • CMPS Health Care
  • Exchange
  • TKNO Nasdaq
  • CMPS Nasdaq
  • Market Cap
  • TKNO 356.4M
  • CMPS 364.9M
  • IPO Year
  • TKNO 2021
  • CMPS 2020
  • Fundamental
  • Price
  • TKNO $5.19
  • CMPS $2.76
  • Analyst Decision
  • TKNO Buy
  • CMPS Strong Buy
  • Analyst Count
  • TKNO 1
  • CMPS 7
  • Target Price
  • TKNO $5.00
  • CMPS $17.83
  • AVG Volume (30 Days)
  • TKNO 232.2K
  • CMPS 4.3M
  • Earning Date
  • TKNO 08-12-2025
  • CMPS 07-31-2025
  • Dividend Yield
  • TKNO N/A
  • CMPS N/A
  • EPS Growth
  • TKNO N/A
  • CMPS N/A
  • EPS
  • TKNO N/A
  • CMPS N/A
  • Revenue
  • TKNO $38,250,000.00
  • CMPS N/A
  • Revenue This Year
  • TKNO $8.73
  • CMPS N/A
  • Revenue Next Year
  • TKNO $16.53
  • CMPS N/A
  • P/E Ratio
  • TKNO N/A
  • CMPS N/A
  • Revenue Growth
  • TKNO 3.79
  • CMPS N/A
  • 52 Week Low
  • TKNO $1.16
  • CMPS $2.25
  • 52 Week High
  • TKNO $10.37
  • CMPS $8.54
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 33.96
  • CMPS 33.47
  • Support Level
  • TKNO $5.15
  • CMPS $2.25
  • Resistance Level
  • TKNO $5.65
  • CMPS $5.15
  • Average True Range (ATR)
  • TKNO 0.34
  • CMPS 0.42
  • MACD
  • TKNO -0.04
  • CMPS -0.26
  • Stochastic Oscillator
  • TKNO 25.68
  • CMPS 17.59

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Share on Social Networks: